Detalles de la búsqueda
1.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Ann Oncol
; 26(5): 873-879, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25725046
2.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Ann Oncol
; 26(12): 2505-6, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467471
3.
The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer.
J Geriatr Oncol
; 9(2): 152-162, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29167064
4.
Adjuvant chemotherapy in 2005: standards and beyond.
Breast
; 14(6): 439-45, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16188441
5.
Better predictive factors in endocrine-responsive breast cancer than the estrogen receptor itself.
Int J Gynecol Cancer
; 16 Suppl 2: 533-7, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17010067
Resultados
1 -
5
de 5
1
Próxima >
>>